Neoplasms: all 9,616 studies

Page 69 of 97. Open to participants first (2,508), then studies with results posted, then the rest; newest registration first within each.

• Precarious Elderly Patient Supported For Cancer Impact on Quality Of Life of a Domotic And Remote Assistance Approach for Elderly Patients Supported For Locally Advanced or Metastatic Cancer, Socially IsolatedStatus unknownNCT02829762Not applicable
• A Study to Determine the Excretion Balance, Pharmacokinetics, Metabolism and Absolute Oral Bioavailability of a Single Oral Dose of [14C]-Labeled Idasanutlin and an Intravenous Tracer Dose of [13C]-Labeled Idasanutlin in a Single Cohort of Participants With Solid Tumors (Malignancies)CompletedNCT02828930Phase 1
• Phase 1 Study of Anti-PD-L1 Monoclonal Antibody KN035 to Treat Locally Advanced or Metastatic Solid TumorsCompletedNCT02827968Phase 1
• Phase I/II, FIH, Dose Escalation Trial of TL-895 and Expansion of TL-895 Monotherapy and Combination Therapy With Navtemadlin in Tx-Naïve and R/R CLL/SLL SubjectsActive, not recruitingNCT02825836Phase 1/2
• A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer PatientsCompletedNCT02825563Phase 1
• Sentinel Node Mapping in Women With Cervical and Endometrial CancerCompletedNCT02825355
• A Guided Written Disclosure Intervention to Promote Post-traumatic Growth in Cancer Patients GUIDED WRITTEN DISCLOSURECompletedNCT02824484Not applicable
• Association Between Side Effects Occurrence and Concentrations of Ibrutinib and IdelalisibCompletedNCT02824159
• Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and ItraconazoleCompletedNCT02824042Phase 1
• Clinical and Therapeutic Impact of Molecular Markers in Myeloproliferative DisordersStatus unknownNCT02823210
• Endoplasmic Reticulum Stress and Resistance to Treatments in Ph-negative Myeloproliferative NeoplasmsCompletedNCT02823184
• Effectivity and Safety of Irreversible Electroporation for Refractory Neoplasms in Liver and PancreasStatus unknownNCT02822066Phase 1/2
• Effectivity and Safety of Ultrasound-guided Percutaneously Laser Ablation for Refractory NeoplasmsStatus unknownNCT02822053Phase 1/2
• Sentinel Node Mapping in Women With Endometrial and Cervical CancerActive, not recruitingNCT02820506Not applicable
• A Trial on SBRT Versus MWA for Inoperable Colorectal Liver Metastases (CLM)TerminatedNCT02820194Not applicable
• A Study of TSR-022 in Participants With Advanced Solid Tumors (AMBER)Active, not recruitingNCT02817633Phase 1
• Effectivity and Safety of Endoscopic Ultrasonography-guided Laser Ablation for Refractory NeoplasmsStatus unknownNCT02816944Phase 1/2
• Nivolumab in Combination With Plinabulin in Patients With Metastatic Non-Small Cell Lung Cancer (NSCLC)CompletedNCT02812667Phase 1
• Alisertib and TAK-228 in Participants With Human Papilloma Virus (HPV) Associated MalignanciesWithdrawnNCT02812056Phase 1
• DTI & Tractography in Pediatric Tumor SurgeryStatus unknownNCT02810626Not applicable
• Collection of Tissue Blocks or Slides From Patients With CancerCompletedNCT02810405
• The Role of ctDNA and PBMC in Treatment of Biliary Tract CancerStatus unknownNCT02809898
• An Observational Prospective Long-term Exposure Registry of Adult Patients With Moderate-to-Severe Ulcerative ColitisActive, not recruitingNCT02808780
• Fragmentation of Elastin as a Biological Marker of Frailty and Impact in Tumor Progression in Elderly Patients With CancerCompletedNCT02807129Not applicable
• PEG-rhG-CSF in Patients With Malignant Solid Tumors Receiving ChemotherapyCompletedNCT02805166Phase 4
• Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC PatientsStatus unknownNCT02804100
• Pancreatoduodenectomy in Pancreatic and Periampullary TumorsCompletedNCT02803814Not applicable
• A Clinical Trial of Stereotactic Ablative Radiotherapy for Metastatic LymphadenopathyStatus unknownNCT02803151Not applicable
• Epidural Anesthesia-analgesia and Long-term Survival After Lung Cancer SurgeryCompletedNCT02801409Not applicable
• RRx-001 in Combination With Irinotecan in Metastatic or Advanced Cancer (PAYLOAD)TerminatedNCT02801097Phase 1
• Study of Molecular-targeted Therapy Using Zinc Finger Nuclease in Cervical Precancerous LesionsStatus unknownNCT02800369Phase 1
• Clinical Trial of Adjuvant Chemotherapy Followed by Concurrent Chemoradiotherapy Compared With Adjuvant Chemotherapy Alone in Patients With Gallbladder Carcinoma and Extrahepatic CholangiocarcinomaStatus unknownNCT02798510Phase 3
• Combination Adenovirus + Pembrolizumab to Trigger Immune Virus EffectsCompletedNCT02798406Phase 2
• Frameless Fractionated Stereotactic Radiation in Treating Patients With Brain MetastasesCompletedNCT02798029Phase 2
• CEST- Glucose Enhanced MRI for Metastatic Brain TumoursTerminatedNCT02796729Phase 2
• CD22 Targeting CAR-T Therapy Against B Cell Hematological MalignanciesStatus unknownNCT02794961Phase 1/2
• EBUS Score Validation for MalignancyCompletedNCT02793713
• Durvalumab in Pediatric and Adolescent PatientsCompletedNCT02793466Phase 1
• Post-Marketing Study to Assess Complication Rates of Oncology Patients With Ports and Peripheral IVsCompletedNCT02792764
• A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid TumorsCompletedNCT02791334Phase 1
• Comparing of Modified Wet Suction Technique and Dry Suction Technique for EUS-FNA of Solid Occupying LesionsStatus unknownNCT02789371Not applicable
• Assessing the Efficacy of Paclitaxel and Olaparib in Comparison to Paclitaxel / Carboplatin Followed by Epirubicin/Cyclophosphamide as Neoadjuvant Chemotherapy in Patients With HER2-negative Early Breast Cancer and Homologous Recombination DeficiencyCompletedNCT02789332Phase 2
• Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving ChemotherapyCompletedNCT02786524Not applicable
• Study of Matched Unrelated Donor T Cell Infusion for Hematologic Malignancies After Allo-HSCTWithdrawnNCT02786485Phase 1
• Histological Differentiation Grade Predicted by Ultrasound Backscatterer ImagingStatus unknownNCT02786199
• Endorings™ Assisted Colonoscopy Versus Standard Colonoscopy for Polyp DetectionCompletedNCT02785783Not applicable
• Clinical Outcomes of Preoperative and Postoperative Rehabilitation in the Patients With HBP MalignancyCompletedNCT02784353Not applicable
• Clinical Utilization of Newly Approved Oncology MedicationsStatus unknownNCT02783885
• Evaluation of the Initial Prescription of Ketamine and Milnacipran in Depression in Patients With a Progressive DiseaseCompletedNCT02783430Phase 2/3
• Diffusion-Weighted MRI for Liver MetastasisCompletedNCT02781935
• Limiting Chemotherapy Side Effects by Using MoxaStatus unknownNCT02781155Phase 1/2
• Human Papillomavirus (HPV) Self-sampling as a Test of Cure After Treatment of Cervical Intra-epithelial NeoplasiaCompletedNCT02780960Not applicable
• Next Generation Personalized Neuroblastoma TherapyTerminatedNCT02780128Phase 1
• A Study of AL2846 on Tolerance and PharmacokineticsStatus unknownNCT02779699Phase 1
• A Study of Prexasertib (LY2606368) in Participants With Advanced CancerCompletedNCT02778126Phase 1
• Tumor Monitoring Using Thermography During Radiation TherapyStatus unknownNCT02776995Not applicable
• National Swiss Sarcoma Cohort StudyTerminatedNCT02775799
• Efficacy Study of Pembrolizumab in Relapsed, Locally Recurrent Squamous Cell Cancer of the Head and NeckActive, not recruitingNCT02769520Phase 2
• PERCIST Criteria for Response Evaluation With Solid TumorsStatus unknownNCT02765620
• A Phase I Trial of SHR3162 in Subjects With Advanced Solid TumorsCompletedNCT02759666Phase 1
• A Phase I Trial of HS-10241 in Solid TumorsCompletedNCT02759640Phase 1
• Associating Liver Partition With Portal Vein Ligation for Staged Hepatectomy (ALPPS) vs. Two-Stage Hepatectomy (TSH) for Marginally Resectable Colorectal Liver Metastases (CRLM)Status unknownNCT02758977Not applicable
• Matching Patients With Hematologic Malignancy to Adequate Clinical TrialsStatus unknownNCT02758080Not applicable
• Validation of 3 Dimensional Laparoscopic System in Disral Pancreatectomy and SplenectomyCompletedNCT02757690Phase 4
• Dose Escalation Versus Standard in Laryngopharyngeal CancersCompletedNCT02757222Not applicable
• Assessing the Impact of Electronic Capture of Patient Reported Outcomes in Radiation OncologyCompletedNCT02756767
• Personalized PRRT of Neuroendocrine TumorsActive, not recruitingNCT02754297Phase 2
• Nano MRI on 7 Tesla in Rectal and Breast CancerStatus unknownNCT02751606Phase 3
• A Study of ERY974 in Patient With Advanced Solid TumorsCompletedNCT02748837Phase 1
• Lucitanib (E3810) in Patients With Advanced Cancer and FGFR, VEGFR, or PDGFR Pathway AberrationsWithdrawnNCT02747797Phase 2
• Treating Relapsed/Recurrent/Refractory Pediatric Solid Tumors With Sorafenib in Combination With IrinotecanWithdrawnNCT02747537Phase 2
• Phase I Study of BAY1436032 in IDH1-mutant Advanced Solid TumorsCompletedNCT02746081Phase 1
• A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted AgentsCompletedNCT02745769Phase 1
• A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid TumorsCompletedNCT02743637Phase 1
• Pbi-shRNA™ EWS/FLI1 Type 1 LPX in Subjects With Advanced Ewing's SarcomaCompletedNCT02736565Phase 1
• Peptide Receptor Radionuclide Therapy With 177Lu-Dotatate Associated With Metronomic Capecitabine In Patients Affected By Aggressive Gastro-Etero-Pancreatic Neuroendocrine TumorsCompletedNCT02736500Phase 1/2
• Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear TestCompletedNCT02734303
• A Study to Evaluate the Safety, Tolerability, MTD, PK, and Activity of Oraxol in Subjects w Adv. MalignanciesCompletedNCT02730481Phase 1
• Take the Fight in Supporting and Empowering Patients With CancerTerminatedNCT02729883Not applicable
• The Importance of Albumin Infusion Rate for Plasma Volume Expansion Following Major Abdominal SurgeryCompletedNCT02728921Phase 4
• Developing a Symptom List for Children With CancerStatus unknownNCT02726815
• A Phase 1b Study of Demcizumab Plus Pembrolizumab in Locally Advanced or Metastatic Solid TumorsCompletedNCT02722954Phase 1
• A Study to Evaluate the Safety and Tolerability of Using the SHR-1210 by Advanced Solid Tumor SubjectsCompletedNCT02721589Phase 1
• Safety and Immunogenicity of Personalized Genomic Vaccine to Treat MalignanciesCompletedNCT02721043Phase 1
• Phase II Study of Fludarabine, Cytarabine (ARA-C) and Erwinase IV in Patients With Relapsed or Refractory Hematologic MalignanciesWithdrawnNCT02718755Phase 2
• 18F-FDG Uptake Measurements in Malignant Solid Tumors on PET/CT and PET/MRCompletedNCT02717572Phase 1
• SRS and Nivolumab in Treating Patients With Newly Diagnosed Melanoma Metastases in the Brain or SpineCompletedNCT02716948Phase 1
• Feasibility of a 8-week Telerehabilitation Program for Patients With Thoracic Neoplasia Receiving ChemotherapyStatus unknownNCT02716493Not applicable
• A Study of the Safety and Efficacy of Atezolizumab Administered in Combination With Bevacizumab and/or Other Treatments in Participants With Solid TumorsCompletedNCT02715531Phase 1
• Study of TSR-042, an Anti-programmed Cell Death-1 Receptor (PD-1) Monoclonal Antibody, in Participants With Advanced Solid TumorsActive, not recruitingNCT02715284Phase 1
• Precise Treatment in Hepatobiliary Cancers (PTHBC)Status unknownNCT02715089
• Low-Cost Imaging for Cervical Cancer Prevention in the Texas Lower Rio Grande ValleyTerminatedNCT02714439Early Phase 1
• A Primary Palliative Care Intervention for Patients With Advanced CancerCompletedNCT02712229Not applicable
• Consolidation Therapy in Patients With Hematologic MalignanciesWithdrawnNCT02709993Phase 1/2
• Pilot Testing of a Real-Time Oncogeriatric Teleconsultation System Using the Total Cancer Care™ DatabaseCompletedNCT02708381
• A Trial to Strengthen Existential Resiliency Among Women With Metastatic Breast CancerCompletedNCT02707510Not applicable
• Prospective Screening for Patient-Specific Genotypes and Phenotypes That Influence Drug Dosing and Trial Selection in Cancer PatientsTerminatedNCT02706652
• A Drug-Drug Interaction Study to Assess the Effect of Trametinib on the Pharmacokinetics of an Oral Contraceptive in Female Patients With Solid TumorsCompletedNCT02705963Phase 1
• Consolidation Therapy in Patients With Metastatic Solid MalignanciesWithdrawnNCT02705703Phase 1/2
• A Study to Evaluate MEDI0562 in Combination With Immune Therapeutic Agents in Adult Subjects With Advanced Solid TumorsCompletedNCT02705482Phase 1

← Neoplasms overview